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Summary 
NF-KB, a heterodimeric transcription factor composed 
of p50 and p65 subunits, can be activated in many cell 
types and is thought to regulate a wide variety of genes 
involved in immune function and development. Mice 
lacking the p50 subunit of NF-KB show no develop- 
mental abnormalities, but exhibit multifocal defects in 
immune responses involving B lymphocytes and non- 
specific responses to infection. B cells do not prolif- 
erate in response to bacterial lipopolysaccharide and 
are defective in basal and specific antibody produc- 
tion. Mice lacking p50 are unable effectively to clear 
L. monocytogenes and are more susceptible to infec- 
tion with S. pneumoniae, but are more resistant to 
infection with murine encephalomyocarditis virus. 
These data support the role of NF-KB as a vital tran- 
scription factor for both specific and nonspecific im- 
mune responses, but do not indicate a developmental 
role for the factor. 
Introduction 
NF-KB is a heterodimeric transcription factor composed 
of p50 and p65 subunits that was originally identified as 
an inducible B cell-specific factor able to bind to the KB 
motif in the intronic 1< light chain enhancer (Sen and Balti- 
more, 1986a, 1986b). On the basis of the correlation be- 
tween induction of NF-KB and K light chain gene expres- 
sion, NF-~<B was thought to be a key regulatory molecule 
in 1< light chain gene activation and perhaps to be involved 
in the maturation of pre-B to B cells (Sen and Baltimore, 
1987). NF-KB is now recognized to be a ubiquitously ex- 
pressed factor that is present in most cell types in an induc- 
ible cytoplasmic form (for reviews see Grilli et al., 1991; 
Grimm and Baeuerle, 1993). A wide range of stimuli, in- 
cluding viruses, bacterial lipopolysaccharide (LPS), en- 
gagement of antigen receptors, stress factors, and cytok- 
ines lead to translocation of NF-KB from the cytoplasm to 
the nucleus, where it appears in active form capable of 
binding decameric KB sequence motifs of the general form 
5'-GGGRNNYYCC-3'. An extensive set of genes with puta- 
tive NF-KB-binding sites has been identified, and in many 
of these, the NF-~<B sites appear crucial to the regulation 
of transcription. Putative cellular target genes are largely 
involved in the acute-phase response, inflammation, lym- 
phocyte activation, and cell growth and differentiation. 
These genes include cell-surface molecules involved in 
immune function such as immunoglobulin K light chain, 
class I and II major histocompatibility complex (MHC), and 
cytokines such as interleukin-ll3 (IL-113), IL-2, IL-6, inter- 
feron-13 (IFNI~), and tumor necrosis factor (~ (TNFa). 
Following cloning of genes encoding the p50 and p65 
subunits of NF-KB (Ghosh et al., 1990; Kieran et al., 1990; 
Nolan et al., 1991), it became evident that p50 and p65 
were members of a larger NF-KB/Rel family of transcrip- 
tion factors. There are currently five members of the NF- 
KB/Rel family that have been identified in vertebrates: 
NFKB1 (p50 and its precursor, p105), NFKB2 (p52 and its 
precursor, pl00), p65 (RelA), c-Rel (Rel), and RelB (for 
review see Nolan and Baltimore, 1992). Most of these fam- 
ily members can heterodimerize in vitro. As dimers, all 
five proteins can form complexes with KB DNA sequence 
motifs, and all have been shown to affect transcription of 
KB reporter genes positively or negatively when assayed 
following transfection. 
Despite extensive knowledge of the biochemical and 
molecular properties of these family members, little is 
known about the roles of these transcription factors in vivo 
(for review see Liou and Baltimore, 1993). The control of 
different heterodimers within cells, their tissue- and cell 
type-specific distribution and regulation within developing 
organisms, and the relationship of different heterodimeric 
complexes to the in vivo regulation of transcription of indi- 
vidual genes and regulatory gene networks are all poorly 
understood issues. These issues all relate to a central 
unresolved problem of how so many diverse input signals 
are coherently coupled to so many different ranscriptional 
responses through the NF-KB/Rel family. 
To develop an understanding of the physiological roles 
of NF-KB, we have initiated a gene targeting program to 
generate mice lacking individual and multiple subunits. 
Here we report the effects of ablating the portion of the 
NFKB1 gene encoding the p50 subunit. The in vivo conse- 
quences of this gene targeting on both gene expression 
and induction of NF-~<B reveal complex focal defects in 
NF-~B regulation that were not apparent in previous in 
vitro studies. Surprisingly, many genes with apparent bind- 
ing sites for NF-KB and even for p50 homodimer are ex- 
pressed normally by cells lacking p50. Our results indicate 
that the p50 subunit of NF-KB does not play a development 
role in the immune system (or elsewhere), but is a critical 
component of gene programs regulating both responses 
of mature lymphocytes and nonspecific immune re- 




Targeting the NFKB1 Gene and Generation 
of Mutant p50 + Mice 
The p50 subunit of NF-KB is not synthesized as an active 
DNA-binding protein, but is generated by proteolytic pro- 
cessing of a 105 kDa precursor called p105 that contains 
p50 in its N-terminal half.(Ghosh et al., 1990; Kieran et 
al., 1990) and IKB-y in its C-terminal half (Inoue et al., 
1992; Liou et al., 1992). The NFKB1 gene encodes both 
p105 and IKB-y mRNAs, probably through separate pro- 
moters. Members of the NF-KB/Rel family of transcription 
factors share a conserved N-terminal 300 amino acid Rel 
homology domain responsible for both dimerization and 
binding to KB sequence motifs (Grimm and Baeuerle, 
1993; Logeat et al., 1991). The construct pp50KO used 
for targeted disruption of the NFKB1 gene was designed 
to insert a PGK-neo cassette into exon 6 of the NFKB1 
gene (Figure 1A). Exon 6 encodes residues 134-187 that 
lie within the Rel homology domain that extends from resi- 
dues 30-330. This disruption would be expected to pro- 
duce a truncated polypeptide that had no ability to bind 
DNA or dimerize with itself or other NF-KB/Rel family mem- 
bers. Targeted NFKB1 alleles should be unable to direct 
synthesis of the p105 precursor to p50, but should not 
affect IKB~ synthesis from an internally promoted mRNA. 
The linearized targeting vector was electroporated into 
E14 embryonic stem cells, and the average frequency of 
homologous recombination was about 1 in 25 G418 R colo- 
nies. Several clones were used to generate chimeric mice, 
and homozygous mice were generated by intercrosses of 
heterozygous mice (Figure 1B). To verify that the gene 
disruption created a null mutation, we examined expres- 
sion of the p105 protein in spleen (Figure 1C). In tissue 
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Figure 1. ProductiOn of Mice Lacking the p50 Subunit of NF-KB 
(A) The NFKB1 locus and targeting construct. Map of the region of 
the NFKB1 gene encoding the Rel homology domain of p105. Exons 
are represented by open boxes. The length of diagnostic EcoRV re- 
striction fragments and the probe used for Southern blot analysis are 
shown. 
(B) Southern blot analysis of EcoRV-digested tail DNAs hybridized 
with probe A. 
(C) Western blot analysis of spleen lysates from mice genotyped as 
wild type, homozygous, and heterozygous for the disrupted NFKB1 
allele. The protein blot was incubated with serum specific to mouse 
p50. Locations of specific p105 and p50 bands are indicated by arrows. 
lysates from mice that were genotyped as homozygous 
for the disrupted NFKB1 allele, both the p105 precursor 
and processed p50 protein were undetectable by an anti- 
p50 serum. These results indicate that p105 and p50 have 
been functionally inactivated in homozygous mice, which 
we will refer to as p50 + mice. 
When housed under specific pathogen-free conditions, 
p50 + mice showed no differences in size, behavior, life 
span up to 1 year, and reproductive ability when compared 
with littermate controls. They were, however, more prone 
to infection and died more frequently at an earlier age 
when housed under conventional conditions. Both gross 
examination and histological analyses of all organ systems 
were unremarkable. In particular, lymphoid organs, includ- 
ing bone marrow, thymus, spleen, and lymph nodes, had 
normal architecture without evidence of specific patho- 
logic changes (data not shown). 
Normal Mature B and T Cell Subsets 
The normal size and follicular architecture of lymph nodes 
and spleens from p50 + mice suggested that lymphocyte 
populations would be normal. This was confirmed by flow 
cytometric analyses of splenocyte populations (Figure 2). 
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Figure 2. Normal • Light Chain Usage, Class I MHC Expression, and 
Mature B and T Cell Subsets 
Equivalent numbers of lymphocytes were obt~.ined from single cell 
suspensions prepared from spleens of p50 + and control littermates 
(data not shown). Splenocytes were stained with labeled antibodies 
and analyzed by flow cytometry as described in Experimental Proce- 
dures. Percentages of cells in relevant quadrants are indicated. 
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Both numbers and ratios of B and T cells isolated from 
spleens were normal. Analyses of B220 and Thyl.2 sur- 
face expression on splenocytes were unremarkable. 
When B cells were examined for surface immunoglobulin 
expression, normal levels of surface immunoglobulin M 
(IgM) and immunoglobulin D (IgD) were expressed. Inter- 
estingly, light chain usage was unchanged in p50 + mice. 
K light chain was still used in marked preference to k light 
chain. This lack of increase in ~. light chain usage indicates 
that the absence of p50-containing NF-KB/Rel complexes 
did not significantly perturb the developmental program 
of 1< light chain expression in p50-'- B cells. Lymphocyte 
populations in bone marrow showed normal surface ex- 
pression and distribution of B220 and CD43 molecules 
(data not shown). Splenic T cells and thymocytes from 
p50 + mice had normal surface expression and distribu- 
tion of CD3e, CD4, CD8, and CD28 molecules (data not 
shown). Interestingly, the surface expression of class I and 
II MHC molecules on p50 + lymphocytes was also normal. 
Expression of the K = class I MHC molecule has been 
thought to involve binding of a p50 homodimer to a KB 
site in the K b promoter (Baldwin and Sharp, 1988; IsraSI 
et al., 1989; Kieran et al., 1990). In addition, N F-~:B-binding 
motifs have been identified in the genes encoding 132- 
microglobulin (Israel et al., 1989) and invariant chain (Pes- 
sara and Koch, 1990), proteins that are involved in class 
I and II MHC expression. 
Composition and Induction of NF-KB/Rel 
Complexes in B Cells 
We have previously described an ordered pattern of NF- 
KB/Rel complexes during different s ages of B cell devel- 
opment: mainly p50 and p65 in pre-B (and non-B) cells, 
a predominance of Rel and p50 in mature B cells, and 
expression of p52 and RelB in plasmacytoma lines (Liou 
et al., 1994). We hypothesized that this sequential induc- 
tion of NF-KB/Rel family proteins reflected the requirement 
for expression of different genes during terminal B cell 
differentiation. It was, therefore, of interest o define what 
effect the absence of p50 had on the cytoplasmic levels 
of other NF-KB/Rel family members in splenic B cells and 
to determine whether any compensation for the loss of 
p50 was occurring. Using antisera whose specificity have 
previously been established (Liou et al., 1994), we sub- 
jected cytoplasmic extracts from resting splenic B cells to 
Western blot analyses to determine the relative amounts 
of different family members that were available in the cy- 
toplasm for induction. Cytoplasmic extracts contained 
equivalent amounts of p52, but amounts of Rel, RelB, and 
p65 were substantially lower in p50 + B cells (Figure 3A). 
Thus, there was no evidence for up-regulation in p50 + B 
cells of other family members, particularly p52, the closest 
homolog of p50. These results imply that compensation 
by other family members was not occurring at a substantial 
level in B cells. Interestingly, similar Western blot analyses 
of cytoplasmic extracts from control and p50 + embryonic 
fibroblast lines revealed that levels of p52, Rel, RelB, and 
p65 were unchanged in p50 + fibroblast lines, implying 
that the observed decrease in Rel, RelB, and p65 in p50 + 
B cells was cell type specific (data not shown). 
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Figure 3. Composition and Induction of NF-KB/Rel Complexes in 
B Cells 
(A) Western blot analysis of cytoplasmic extracts prepared from puri- 
fied control and p50 + B cells. Each protein blot was incubated with 
serum specific to p52, Rel, RelB, and p65. An additional preparation 
of control and p50 + B cell cytoplasmic extracts containing less protein 
was included in the first two lanes of the p65 Western blot to demon- 
strate more clearly the difference in p65 protein levels. Arrows indicate 
location of specific protein bands, blockable by addition of antigen. 
(B) Induction of NF-KB/Rel complexes by LPS and anti-lgM treatment. 
EMSA of 5 I~g of nuclear extracts from small resting control and p50 + 
B cells prepared in parallel after 4 hr in medium alone (solid line) or 
treatment with LPS (10 l~g/ml) oranti-lgM antibody (30 I~g/ml). A loop 
oligonucleotide probe containing the class I MHC KB site was used. 
(C) Composition of NF-KB/Rel complexes induced by anti-lgM treat- 
ment in control and p50 + B cells assessed by EMSA with antibody 
inhibition. Purified specific antibodies (5 p.g) to each N F-KB/Rel compo- 
nent were preincubated with nuclear extracts prior to addition of the 
class I MHC KB oligonucleotide probe. Control (ctrl) represents normal 
rabbit serum. Specific complexes were inhibited by competition with 
1 ng and 5 ng of unlabeled oligonucleotide containing a class I MHC 
KB site, but not a mutant (mut) KB site. 
We were interested in testing whether the reduction in 
cytoplasmic NF-~B/Rel complexes in p50 + B cells af- 
fected the ability of these complexes to be induced. Both 
bacterial LPS and engagement of antigen receptor are 
potent inducers of translocation of NF-KB/Rel complexes 
in B cells (Sen and Baltimore, 1986a; Atchison and Perry, 
1987; Liu et al., 1991). To mimic antigen receptor engage- 
ment, we used anti-lgM antibody. We chose concentra- 
tions of inducers that caused equivalent induction of NF- 
KB/Rel complexes at 4 hr in wild-type small resting B cells 
that were rigorously purified from splenocytes (Figure 3B). 
Induction of NF-KB/Rel complexes was assayed by elec- 
trophoretic mobility shift analysis (EMSA) using equivalent 
amounts of nuclear extracts from treated and untreated 
B cells. When analyzed in parallel with control B cells, 
p50 + B cells showed less induction of NF-KB/Rel com- 
plexes with anti-lgM treatment and no induction with LPS 
treatment. Interestingly, the low amount of constitutive nu- 
clear NF-KB in wild-type cells was not evident in untreated 
p50 + B cells. 
The composition of NF-~:B/Rel complexes induced by 
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anti-lgM antibody was determined by EMSA in which nu- 
clear extracts were preincubated with specific antisera to 
individual NF-KB/Rel family members (Figure 3C). In wild- 
type B cells, anti-p50 serum inhibited nearly all of the bind- 
ing of induced complexes, whereas anti-p65 and anti-Rel 
sera each only partially inhibited binding, and anti-p52 and 
anti-RelB sera had little effect. These results imply that 
p50-p65 and p50-Rel were the major NF-KB/Rel com- 
plexes induced in wild-type B cells by anti-lgM antibody. 
The same complexes were also induced in wild-type B cells 
by LPS treatment (data not shown). In contrast, the com- 
plexes induced by anti-lgM antibody in p50 -/- B cells were 
composed primarily of Rel and p65 with, of course, no p50 
and no evident p52. Thus, despite the similar induction of 
NF-KB complexes by anti-lgM and LPS in wild-type B cells, 
the absence of p50 revealed a striking difference in the 
ability of these two inducers to activate translocation of 
complexes containing p65 and Rel. 
Induction of NF-KB/Rel Complexes Activates 
B Cell Proliferation 
The differential ability of anti-lgM and LPS treatment o 
cause translocation of NF-KB/Rel complexes in p50 -~- 
B cells allowed us to ask whether induction of NF-KB/Rel 
complexes is an important signal for B cell proliferation, 
since both anti-lgM antibody and LPS are potent B cell 
mitogens (Figure 4). In multiple xperiments, no reproduc- 
ible differences were observed in the proliferative re- 
sponses of p50 +~- and p50 ÷~÷ B cells to either mitogen. 
Purified p50 -~- B cells also proliferated in response to in- 
creasing amounts of anti-lgM antibody, although some- 
what more weakly than control B cells. In contrast, purified 
p50 -~- B cells were unresponsive to a range of LPS concen- 
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Figure 4. Induction of B Cell Proliferation Correlates with Induction 
of NF-KB/Rel Complexes 
Proliferation of small resting B cells treated with either anti-lgM anti- 
body or LPS. Small resting B cells were purified from spleens of p50 -~- 
(open circles), p50 +/- (stippled circles), or wild-type (closed circles) 
mice. 
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Figure 5. Resting and Specific Antibody Production 
Each symbol represents the value obtained from one animal by ELISA. 
(A) Serum concentrations of immunoglobulin isotypes from unimmu- 
nized control (closed circles) and p50 + (open circles) mice. Total rest- 
ing serum immunoglobulin evels are given in relative units. 
(B) T cell-dependent antibody response. At 6 and 15 days after immu- 
nization with NP~5-CG, concentrations oftotal NP-specific antibodies 
in sera were determined from control wild-type (closed circles) and 
p50 +~ (stippled circles) and from p50 -~- (open circles) mice. Relative 
amounts of NP-specific IgM antibodies at day 6 and NP-specific anti- 
bodies of the indicated isotypes at day 15 were determined for control 
(closed circles) and p50 + (open circles) mice. 
B cells. LPS treatment of p50 -/- B cells did, however, in- 
duce class II MHC up-regulation (data not shown), sug- 
gesting that other signal transduction pathways were still 
being activated by LPS in p50 -~- B cells and that these 
B cells were fully capable of binding LPS. Thus, the ability 
of these two inducers to activate NF-KB/Rel complexes 
correlated with their ability to stimulate B cell proliferation. 
These results indicate that the induction of NF-KB/Rel 
complexes plays a critical role in activating transcription 
of genes involved in B cell mitogenic responses. 
Basal and Specific Antibody Production 
To assess basal production of antibodies in unimmunized 
mice, we measured resting serum immunoglobulin levels 
in p50 -~- and control littermates. Interestingly, total serum 
immunoglobulin was 4-fold lower in p50 -~- mice (Figure 
5A). This decrease resulted from a significant reduction 
in all isotypes measured except for IgM, which was slightly 
elevated in p50 + mice. The largest reductions were in 
serum IgE, which was reduced more than 40-fold; serum 
IgG1, which was decreased more than 10-fold; and serum 
IgA, which was decreased 5-fold. These results indicate 
that p50 -~- mice were inefficient in the production of immu- 
noglobulin isotypes that result from heavy chain class 
switching, suggesting that one key cellular event depen- 
dent on p50 is isotype switching. 
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The defects in resting serum immunoglobul in levels 
prompted us to examine whether p50 ¢- mice were able 
to mount effective humoral respor~ses when immunized 
with specific antigens. Littermates were immunized with a 
T ce l l -dependent  antigen, NP~s-CG, and anti-NP antibody 
production was measured (Figure 5B). Total NP-binding 
antibodies were greatly lower in p50 + mice compared with 
control l ittermates both 6 and 15 days after immunization. 
Unlike resting serum immunoglobul in levels, in which we 
observed considerable variation in the reduction of individ- 
ual isotypes, NP-specific antibodies of different IgG iso- 
types were all substantially reduced relative to control re- 
sponses. Thus, the p50 subunit of NF-KB is apparently 
an essential component of the gene regulatory programs 
that direct ant ibody production in response to specific im- 
munogens. 
Responses  to Pathogens  
Given the presence of ~:B sites in multiple genes involved 
in immune and acute-phase responses, we were inter- 
ested in testing whether NF-KB plays a critical role in re- 
sponses to infection with different pathogens. The course 
of disease with major classes of infectious pathogens was 
examined in p50 + and control mice. Responses to the 
pathogenic intracellular bacterium Listeria monocyto- 
genes, the extracel lular gram-posit ive bacterium Strepto- 
coccus pneumoniae,  the extracellular gram-negative bac- 
teria Haemophi lus influenzae and Escherichia coil K1, and 
the murine encephalomyocardit is  (EMC) virus revealed 
striking differences in outcome between p50 -~- and control 
mice that highlight the complex involvement of p50 in tran- 
scriptional responses to infection. 
L. monocytogenes, an intracellular bacterium, can sur- 
vive in nonactivated macrophages. Clearance of infection 
requires activation of macrophages by cytokines pro- 
duced by T and NK cells (Bancroft et al., 1991). When 
infected with L. monocytogenes, p50 + mice eradicated 
extracellular bacteria, but were impaired in elimination of 
intracellular bacteria. At 6 days after intraperitoneal injec- 
tion of 5000 bacteria, control mice had few or no splenic 
or peritoneal bacteria while p50 + Iittermates had several 
thousand splenic, but no peritoneal, bacteria (Figure 6A). 
This defective clearance likely reflects a defect in macro- 
phage activation, rather than a defect in phagocytic cell 
number or basal phagocytic activity. Both resting perito- 
neal macrophages and blood neutrophils from p50 + mice 
were present in normal numbers and had normal phago- 
cytic activity when assayed for their ability to ingest opso- 
nized zymosan particles (data not shown). These results 
suggest that extracellular L. monocytogenes were phago- 
cytosed normally in p50 + mice and that the defective 
clearance of intracellular L. monocytogenes resulted from 
a defect in the activation of macrophages by cytokines. 
Although p50 + mice el iminated extracellular L. mono- 
cytogenes, control of the replication of an aggressive, ex- 
tracellular, and gram-positive pathogen, S. pneumoniae, 
was compromised. In multiple experiments, when lit- 
termates were injected intraperitoneally with 100 S. pneu- 
moniae bacteria, p50 + mice typically died around 24 hr, 
while control l ittermates took between 36 and 72 hr to 
succumb, with occasional control animals surviving (Fig- 
ure 6B). A small increase in survival time for wild-type over 
p50 ÷¢ littermates was the only difference we consistently 
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Figure 6. In Vivo Responses to Pathogens 
Each circle represents an individual p504 
(open circles), p50 +/- (stippled circles), or wild- 
type (closed circles) animal. 
(A) Defective clearance of L. monocytogenes. 
Mice were injected intraperitoneally with 5 x 
103 cfu of L. monocytogenes and sacrificed 6 
days after inoculation. Each circle represents 
the bacterial colony-forming unit (cfu) from the 
spleen homogenate of a single animal. 
(B) Increased susceptibility to S. pneumoniae. 
Mice were injected intraperitoneally with 100 
encapsulated S. pneumoniae bacteria, and the 
percentage of surviving mice was monitored 
over time. Of five similar experiments, using 
three littermates in each group, one experi- 
ment is shown. 
(C) Increased resistance to infection with EMC 
virus. Mice were injected intraperitoneally with 
-300 pfu of murine EMC virus, and the per- 
centage of surviving mice was monitored over time. Of three similar experiments, using three p50 / and four control littermates in each group, 
one experiment is shown. 
(D) Cytokine production from LPS-stimulated resting peritoneal macrophages. Relative amounts (mean _ SD) of cytokines in 12 hr culture 
supernatants from LPS-stimulated resting peritoneal macrophages from individual animals were assayed from control (closed bars) and p50 ~ 
(open bars) mice. IL-6, TNFa, and IL-lc~ production is shown with cytokine production from control resting peritoneal macrophages normalized 
to 100%. In experiment 1, five p50 -/- and three control mice were used. In experiment 2, two p50 -~- and five control mice were used. 
(E) Representative blood smears from p50 -~- and control mice 20 hr postinoculation with S. pneumoniae. 
(F) Induction of IFN[B transcription in p50 ~ (lanes 2 and 3) and control (lanes 1, 4, and 5) embryonic fibroblasts by Sendal virus. Embryonic 
fibroblasts were prepared from littermate embryos and either infected (plus) or mock infected (minus) with Sendal virus. Total cellular RNA was 
prepared 4 hr after infection, and 10 ~zg was used for Northern blot analysis. Induced IFN~B levels in arbitrary units (quantitated by Phosphorlmager) 
were 29 _ 3.5 for p50 ~ and 12 - 4.3 for control embryonic fibroblasts. 
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mice. p50 -j- mice died from overwhelming sepsis, appar- 
ently secondary to an inability to confine the infection lo- 
cally to the peritoneum. In blood smears taken 20 hr after 
infection, control mice had no visible bacteria, while p50 -~- 
mice had numerous encapsulated diplococci per high 
power field (Figure 6E). S. pneumoniae bacteria were seen 
extensively throughout all organ systems examined in 
moribund p50 -~- mice. 
The defect in control of S. pneumoniae did not extend 
to the gram-negative pathogens H. influenzae and E. coil 
K1, despite observed defects in both B cell and macro- 
phage responses to LPS. The production of the early 
acute-phase reactants TNF~, IL-1, and IL-6 by macro- 
phages stimulated with LPS is thought o involve regula- 
tion by NF-~<B-binding sites in the promoters of these 
genes (Collart et al., 1990; Hiscott et al., 1993; Liebermann 
and Baltimore, 1990). When cytokine release was mea- 
sured from p50 -j- macrophages stimulated with LPS, 
TNFa and IL-1 ~ release were normal, but IL-6 release was 
decreased severalfold relative to control rnacrophages 
(Figure 6D). Nevertheless, both control and p50 -~- mice 
survived infectious challenges with 108 encapsulated type 
b H. influenzae and E. coil K1, although p50 -~- mice did 
undergo a more sustained and elevated bacteremia follow- 
ing intraperitoneal inoculation with H. influenzae (data not 
shown). These findings suggest an important difference 
in the molecular mechanisms underlying sepsis caused 
by the major human pathogens. In the context of gram- 
negative infection, it appears that non-NF-KB-dependent 
activation of important defenses by LPS is sufficient o 
control progression of moderate disease. In contrast, the 
poor survival of p50 -~- mice challenged with S. pneumon- 
iae indicates that bacterial components other than LPS 
may activate additional antimicrobial defense cascades 
dependent upon NF-~<B that are mobilized in the first 24 
hr of disease. 
Enhanced susceptibility to L. monocytogenes and 
S. pneumoniae contrasted with the greater resistance of 
p50 -~- mice to infection with EMC virus, a cytopathic picor- 
navirus that can lead to a fatal encephalopathy. When 
challenged intraperitoneally with -200 pfu of EMC virus, 
p50 -~- mice were surprisingly more resistant han control 
mice to lethal infection (Figure 6C). This resistance was 
relative; a 10-fold higher dose of EMC virus was lethal for 
p50 -~- mice, although the progression to fatal encephalop- 
athy was slower than in control mice. When infectious 
challenges were repeated with totally immunodeficient 
RAGI-~- mice, they succumbed 1-2 days earlier than con- 
trol mice (data not shown), indicating that the protection 
against EMC virus in p50 -j- mice was not due to a lack 
of immune responsiveness by lymphocytes. 
The striking ability of p50 -~- mice to show increased re- 
sistance to infection by EMC virus, in spite of the defects 
we had observed in specific effector lymphocyte and im- 
mune responses to bacteria, prompted us to look at possi- 
ble antiviral responses that might be augmented in p50 -~- 
mice. IFNI3 is a type I IFN that is produced primarily by 
fibroblasts in response to viral infection. IFNI3 mRNA is 
normally undetectable in primary fibroblasts, but high lev- 
els of this mRNA are induced when the cells are treated 
with virus (Goodbourn et al., 1985). This activation of IFNJ3 
gene expression has been thought o involve viral induc- 
tion of NF-KB that is subsequently bound to a virus- 
inducible transcriptional enhancer in the IFNl~ promoter 
region (Lenardo et al., 1989; Maniatis et al., 1992). We 
examined the induction of IFN~ gene transcription by Sen- 
dai virus infection of embryonic fibroblasts. Interestingly, 
induced levels of IFNI3 gene transcription were severalfold 
higher in virally infected p50 -~- embryonic fibroblasts than 
in control fibroblasts (Figure 6F). This result suggested 
that the absence of p50 in embryonic fibroblasts aug- 
mented the antiviral IFNJ3 response and could explain the 
increased resistance to EMC virus. 
Discussion 
Targeted disru ption of the NFKB 1 gene encoding the p105 
precursor of the p50 subunit of NF-KB leads to apparently 
normal animals and, in particular, to unimpaired evelop- 
ment of the immune system. The presence of a phenotypi- 
cally intact immune system has allowed us to define the 
role of the transcription factor p50 in immune responses. 
Our results support a model in which NF-~<B and other 
p50-containing complexes play no developmental role, but 
have evolved to be rapid response elements in both activa- 
tion of lymphocytes and nonspecific immune responses 
to pathogens. 
One difficulty in interpreting the results of gene targeting 
experiments involving a single member of a family of re- 
lated proteins is that compensation, redundancy, or both 
by other family members may mask the actual importance 
of a particular family member. While a definitive assess- 
ment of the in vivo role of NF-~<B must await characteriza- 
tion of mice that are lacking both p50 and p65 subunits, 
characterization of mutant mice lacking RelB provide sup- 
port for the view that individual NF-KB/Rel family members 
play distinctive roles that cannot be compensated for by 
other family members (Weih et al., 1995 [this issue of Cell]). 
Mice lacking RelB exhibit marked disregulation of the he- 
matopoietic system, including myeloid hyperplasia, sple- 
nomegaly due to extramedullary hematopoiesis, and 
multifocal inflammatory infiltrates (Weih et al., 1995). This 
split between a primary role in hematopoietic development 
for RelB and a primary role in functional immune re- 
sponses for p50 is reminiscent of the distinction observed 
in Drosophila between the functions of the NF-KB/Rel pro- 
teins dorsal and Dif. Dorsal is involved in dorsal-ventral 
patterning in the Drosophila embryo (Steward, 1987). Dif, 
in contrast, is a rapid-response mediator of primitive im- 
mune responses to bacterial infection in Drosophila (Ip et 
al., 1993). It is likely that the ability of NF-KB/Rel proteins 
to play distinct roles in more primitive organisms has been 
maintained in vertebrates. This demarcation in function 
is likely to be one way in which the NF-KB/Rel family can 
coordinate many distinct input signals with so many dis- 
crete transcriptional outputs. 
NF-KB Regulation of Lymphocyte Responses 
Our results define a critical role for NF-~<B in the control 
of terminal B cell differentiation rather than in the earlier 
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stages of B cell development, in which it has been thought 
to function in regulation of K light chain gene expression. 
Mice lacking the p50 subunit of NF-KB have normal, ma- 
ture B cells in which the frequency of ~ light chain usage 
is normal. These mature B cells, however, exhibit focal 
defects in both mitogenic activation and basal and specific 
antibody production, indicating that NF-KB and other p50- 
containing complexes are key regulators of the activation 
and subsequent responses of mature B cells. We have 
also found that purified T cells lacking p50 proliferate 
poorly in response to T cell receptor and CD28 stimulation 
(data not shown), suggesting that NF-KB also plays a criti- 
cal role in costimulation of T cell proliferation. 
Our results suggest that tissue-specific regulation of NF- 
~<B/Rel complexes in B cells may be essential to the control 
of terminal B cell differentiation. We previously described 
a developmental progression of NF-KB/Rel family member 
usage during different stages of B cell differentiation (Liou 
et al., 1994). We found that the pattern of NF-KB/Rel com- 
plexes seen in terminally differentiated B cells could be 
mimicked by long-term exposu re of pre-B cell lines to LPS. 
This result prompted us to hypothesize a hierarchy among 
NF-KB/Rel complexes in B cells in which the emergence 
of constitutive NF-KB in mature B cells drives the appear- 
ance of subsequent NF-KB/Rel complexes that may be 
important in terminal B cell differentiation. This hypothesis 
may explain why we observe more pleiotropic defects in 
the functional responses of mature B cells than in other 
cell types lacking p50. In both B cells and fibroblasts, the 
primary NF-KB/Rel complex identified by EMSA was NF- 
~<B p50-p65. Nevertheless, the absence of p50 substan- 
tially decreased the cytoplasmic levels of p65, Rel, and 
RelB in B cells, but had no effect on the levels of these 
family members in fibroblasts. This result implied that reg- 
ulation of NF-KB/Rel family members is more tightly cou- 
pled to p50 in B cells than in fibroblasts. This tight coupling 
may reflect the relatively exclusive usage of p50 in hetero- 
dimeric NF-KB/Rel complexes in mature B cells. The pres- 
ence of constitutive nuclear p50-containing NF-KB/Rel 
complexes that is observed uniquely in mature B cells may 
be linked to the ordered emergence of RelB and p52 in 
NF-KB/Rel complexes that occurs during terminal B cell 
differentiation. Inother cell types that lack constitutive nu- 
clear NF-~:B, a hierarchy among NF-KB/Rel complexes 
may not exist, and either compensation or independent 
regulation of non-p50-containing NF-KB/Rel complexes in 
these cell types leads to little detectable change in the 
cytoplasmic levels of other family members in the absence 
of p50. 
Dual Role of p50 in Immune Responses 
The differences in the responses to infection with the three 
pathogens L. monocytogenes, S. pneumoniae, and EMC 
virus highlight he importance of NF-KB in regulating tran- 
scriptional responses to infection and indicate that p50- 
containing NF-KB/Rel complexes can play a dual role in 
either augmenting or decreasing specific immune re- 
sponses. The surprising resistance to infection with EMC 
virus suggested that the absence of p50 was actually aug- 
menting antiviral responses. We observed that virally in- 
fected fibroblasts that were lacking p50 had augmented 
induction of IFN~ transcription in comparison to control 
fibroblasts. This finding may reflect a dual role for p50 that 
has been suggested by several groups. While p50 forms 
potent transcriptional activators when heterodimerized 
with p65, Rel, or RelB, the ability of p50 homodimers to 
function as transcriptional activators has been more un- 
certain. While p50 homodimers have been reported to be 
transcriptionally active in cell-free transcription systems 
(Fujita et al., 1992; Kretzschmar et al., 1992), a number 
of studies strongly suggest that p50 homodimers lack a 
transcriptional ctivation domain and may be involved in 
transcriptional repression (Franzoso et al., 1992; Kang et 
al., 1992). While our results may be viewed as support for 
a model in which p50 homodimers are involved in postin- 
duction repression of IFNI3 gene transcription, they do not, 
as yet, allow us to distinguish between this model and the 
replacement of p50-p65 heterodimers in p50 + fibroblasts 
with other more potent NF-~<B/Rel transactivators at the 
KB site in the IFNI3 gene. These findings, nevertheless, 
do demonstrate that the p50 subunit of NF-KB allows for 
down-regulation of transcriptional responses that may have 
important in vivo consequences in response to pathogens. 
Regulation by the NF-KB/Rel Family 
The in vivo consequences of gene targeting of the p50 
subunit of NF-KB on the expression of genes for which 
extensive vidence for NF-KB regulation has been demon- 
strated reveal complex focal defects in NF-KB regulation 
that are difficult o predict based upon previous in vitro 
studies. For instance, expression of many genes, such as 
immunoglobulin 1< light chain, class I MHC, and TNFa, 
was not affected by the absence of pS0. In contrast, ex- 
pression of genes such as IL-6 was reduced, whereas 
transcription of genes like IFN~ was augmented in the 
absence of p50. These results highlight our ignorance of 
the true in vivo regulators of transcription at particular KB 
sites in individual genes and suggest that many genes 
with KB sites are either not regulated by NF-KB or can be 
regulated by other NF-~B/Rel complexes in the absence 
of p50. In fact, our results with B cells suggest that p65- 
p65 or p65-Rel dimers may serve many of the functions 
in B cells that were previously ascribed to p50-p65. The 
unpredictable focal defects in NF-KB regulation that we 
observed in mice lacking p50 extended not only to the 
transcriptional regulation of individual genes but also to 
the induction of NF-KB/Rel complexes by different stimuli. 
We observed, for example, that while both LPS and anti- 
gen receptor stimulation are viewed as potent inducers of 
NF-KB/Rel complexes in wild-type B cells, the absence of 
p50-containing complexes revealed a differential ability 
to induce complexes involving p65 and Rel by antigen 
receptor stimulation, but not by LPS. The focal nature of 
the defects in transcription and induction that we have 
observed in p50 + mice strongly implies that individual 
NF-KB/Rel complexes do play distinctive roles in the regu- 
lation of transcription of specific genes. It further suggests 
that we are begin ning to reveal distinct modes of regulation 
in knockout mice, not easily assessed by other ap- 
proaches, that play an important role in coupling distinct 
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input s ignals  with t ranscr ipt ional  outputs  through individ- 
ual NF-~B/Re l  fami ly  members .  
The  phys io logica l  role of the t ranscr ipt ion factor  p50 be- 
comes  c learer  when we shift  our  focus  f rom the regulat ion 
of  individual  genes  to the regulat ion of  gene  networks  con- 
trol l ing more complex  in vivo processes .  Here  we f ind that 
p50 is critical for pro l i ferat ive responses  of  lymphocytes ,  
product ion of  speci f ic  ant ibodies,  and nonspec i f i c  immune 
responses  to severa l  pathogens ,  but is not essent ia l  for 
the deve lopment  of the immune system. Th is  lack of a 
deve lopmenta l  phenotype  in p50 -~- mice is str ik ing when 
v iewed in light of  the complex  d isregulat ion of  the hemato-  
poiet ic  system observed  in mice lacking the more  t issue- 
speci f ica l ly  expressed  RelB fami ly member  (Weih et al., 
1995). These  results indicate that the ubiqui tous ly  ex- 
p ressed  p50 subuni t  of NF-~<B is l ikely to funct ion sole ly 
as a rapid and ple iotropic mediator  of  d i f ferent  acute and 
speci f ic  immune responses  and to play no role in develop-  
ment  of the immune system. 
Experimental Procedures 
Construction of Targeting Vector 
Phage clones of the NFKB1 locus were isolated from a 129/Sv mouse 
liver DNA library (Stratagene). A Notl site was introduced by PCR 
mutagenesis at a position corresponding to residue 160 in exon 6 
(amino acids 134-187 in the Rel homology domain of the p105 protein). 
This facilitated creation of an insertional targeting vector called 
pp50KO that, when linearized, contained 3.7 kb of 5' flanking homolo- 
gous DNA, a PGK-neo cassette (Tybulewicz et al., 1991) in the op- 
posite transcriptional orientation in exon 6, 8.0 kb of 3'flanking homolo- 
gous DNA from the NFKBI gene, and a PGK-tk cassette (Tybulewicz 
et al., 1991) in the opposite transcriptional orientation, followed by the 
Bluescript II vector (Stratagene). 
Generation of Mutant Mice 
The linearized targeting vector pp50KO was electroporated into E14 
embryonic stem cells and G418 R colonies selected as described 
(Plump et al., 1992). Homologous recombinant clones were screened 
by Southern blotting using an external probe. Positive clones demon- 
strated a 9 kb recombinant band, in addition to the 10 kb wild-type 
band, in EcoRV-digested DNA. These clones were expanded and in- 
jected into C57BL6/J blastocysts. Resulting chimeric animals were 
backcrossed to C57BL6/J mice, and germline transmission was scored 
by coat color, p50 ÷~- mice were identified by Southern blotting, and 
brother-sister mating was carried out to generate pS0 ~ mice. 
Western Blots 
Equal amounts of protein lysates from p50 -~- and control tissues and 
cells were loaded onto individual anes of protein gels. After transferral 
to nitrocellulose filters, the blots were stained with Ponceau S to con- 
firm the uniformity of protein loading in each lane. Filters were then 
blocked with 2% nonfat milk-TBST (10 mM Tris-HCI [pH 8.0], 150 mM 
NaCI, 0.05% Tween 20) for 1 hr and incubated with specific antibody at 
a dilution of 1:1000 in 2% nonfat milk-TBST for 2 hr at room tempera- 
ture. After three washes with TBST, filters were incubated with the 
secondary antibody (goat anti-rabbit IgG-horseradish peroxidase con- 
jugate) for 1 hr, and antibody-reactive bandswere revealed by chemilu- 
minescent detection (ECL Western detection kit; Amersharn Interna- 
tional). 
EMSA Assays 
Preparation of nuclear and cytoplasmic extracts, EMSA, and antibody- 
inhibition assays to identify components of NF-~:B/Rel complexes were 
performed as previously described (Liou et al., 1994). A loop oligonu- 
cleotide probe containing the class I MHC ~<B site was used in EMSA 
studies presented here, although similar results were obtained using 
an immunoglobulin ~< ~<B site (Fujita et al., 1992). 
Flow Cytometry 
A FACScan flow cytometer and the Lysis II plotting program were used 
(Becton-Dickinson). First-step monoclonal antibody reagents used 
were R-PE-conjugated anti-Thy1.2 (30H.12), biotinylated anti-lgM (R6- 
60.2), biotinylated anti-K light chain (R5-240), biotinylated anti-~, light 
chain (R26-46), biotinylated anti-H-2K b (AF6-88.5 clone), FITC- 
conjugated anti-CD45R/B220 (RA3-6B2), and biotinylated anti-I-A b 
(AF6-120). Second-step reagents used were streptavidin-R-PE 
(Southern Biotechnology). 
Cell Culture and Proliferation Assays 
Cells were maintained in RPM11640 medium containing 10% defined 
fetal calf serum (Hyclone), penicillin-streptomycin, and 50 mM 13-mer- 
captoethanol. B cells were isolated from spleen cell suspensions ob- 
tained by disrupting spleens between two frosted glass slides. Erythro- 
cytes were removed from splenocytes by ammonium-chloride lysis. 
Resting B cells were purified from these crude spleen populations by 
one round of complement lysis with a Thy1.2 antibody to remove T cells. 
The remaining cells were then fractionated through Percoll gradients 
(Coligan et al., 1993) to isolate small resting B cells, contained between 
66% and 70% Percoll. These cells were collected, washed extensively, 
and incubated in medium for stimulation with anti-lgM or LPS. Prolifera- 
tion assays were performed by plating out 105 purified B cells in tripli- 
cate for each condition in 96-well plates containing 200 ~.1 of media. 
After 60 hr, 1 ~Ci of [methyl-3H]thymidine was added to each well for 
12 hr, and [3H]thymidine incorporation into DNA was quantitated by 
scintillation counter. 
Immunoglobulin Isotype Analysis 
Sera were prepared from 6-week-old p50 ÷ and control p50 ÷j- sex- 
matched littermates. Serum levels in p50 +~- and wild-type littermates 
had previously been determined to be indistinguishable. Immunoglob- 
ulin isotypes were quantitatively determined against isotype standards 
using a sandwich enzyme-linked immunosorbent assay (ELISA) em- 
ploying anti-lgE monoclonal antibodies (PharMingen) for IgE and using 
a pan-specific apture antibody and isotype-specific antibodies conju- 
gated to horseradish peroxidase (Southern Biotechnology) for the 
other isotypes. 
T Cell-Dependent Immune Response 
Littermates were injected intraperitoneally with alum-precipitated 
NPls-CG (100 ~g per mouse), and sera were collected at day 6 for the 
IgM response and at day 15 for the IgG response. Immunoglobulin 
specific to NP was measured using a sandwich ELISA in which NP- 
specific immunoglobulin was captured on plates coated with NP-BSA 
and was analyzed for immunoglobulin isotype. 
Cytokine Release from Peritoneal Macrophages 
Resting peritoneal macrophages were isolated by peritoneal avage 
with 5 ml of ice-cold PBS. Isolated cells were washed and - 108 cells 
plated per condition in 24-well plates. After several hours at 37°C, 
nonadherent cells were removed by two washes with warm PBS, and 
adherent cells were incubated in 0.5 ml of medium containing LPS. 
After removal of supernatants to measure cytokine levels, adherent 
cells were washed in PBS and total protein determined by Coomassie 
protein assay (Pierce) for normalization of cytokine release to numbers 
of adherent cells. Cytokine levels in tissue culture supernatants were 
measured using sandwich ELISAs as described (Sheehan et al., 1969). 
For IL-lc(, anti-mouse IL-la (Genzyme) and polyclonal rabbit anti- 
mouse IL-l(z were used. For IL-6, anti-routine IL-6 (MP5-20F3) and 
biotinylated anti-murine IL-6 (MP5-32Cll) were used. 
Pathogen Challenges 
L. monocytogenes (43251) and murine EMC virus (VR-129B) were 
obtained from the ATCC. S. pneumoniae type 2 strain All, H. influenzae 
type b Eagan, and E. coil K1 were maintained at the Laboratory of 
Molecular Infectious Diseases at The Rockefeller University. 
Induction of IFNp mRNA and Northern Blot Analysis 
For induction by Sendal virus (SPAFAS), embryonic fibroblasts were 
washed twice in PBS and then incubated for 2 hr in serum-free medium 
containing -300 hemagglutinating units per milliliter of virus. Virus 
was removed by washing the cells twice with PBS, and then normal 
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medium was added for a further 2 hr before RNA preparation. Total 
cellular RNA was prepared using TRI-REAGENT (Molecular Research 
Center). A mouse IFN[3 probe containing the first 500 bp of coding 
sequence was hybridized against 10 p.g of RNA. A y-actin probe (Scott 
et al., 1993) was later used to reprobe the same blot. Levels of IFNI~ 
RNA were quantitated by Phosphorlmager and normalized to y-actin. 
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